Ad is loading...
CLRB
Price
$1.56
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
102 days until earnings call
PRAX
Price
$73.68
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
111 days until earnings call
Ad is loading...

CLRB vs PRAX

Header iconCLRB vs PRAX Comparison
Open Charts CLRB vs PRAXBanner chart's image
Cellectar Biosciences
Price$1.56
Change-$0.00 (-0.00%)
Volume$744.17K
CapitalizationN/A
Praxis Precision Medicines
Price$73.68
Change-$0.00 (-0.00%)
Volume$334.23K
CapitalizationN/A
CLRB vs PRAX Comparison Chart
Loading...
CLRB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CLRB vs. PRAX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRB is a Buy and PRAX is a Sell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (CLRB: $1.58 vs. PRAX: $73.06)
Brand notoriety: CLRB and PRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLRB: 396% vs. PRAX: 100%
Market capitalization -- CLRB: $65.21M vs. PRAX: $1.37B
CLRB [@Biotechnology] is valued at $65.21M. PRAX’s [@Biotechnology] market capitalization is $1.37B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRB’s FA Score shows that 0 FA rating(s) are green whilePRAX’s FA Score has 0 green FA rating(s).

  • CLRB’s FA Score: 0 green, 5 red.
  • PRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, PRAX is a better buy in the long-term than CLRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLRB’s TA Score shows that 4 TA indicator(s) are bullish while PRAX’s TA Score has 3 bullish TA indicator(s).

  • CLRB’s TA Score: 4 bullish, 6 bearish.
  • PRAX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both CLRB and PRAX are a bad buy in the short-term.

Price Growth

CLRB (@Biotechnology) experienced а -21.39% price change this week, while PRAX (@Biotechnology) price change was -4.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

CLRB is expected to report earnings on Mar 04, 2025.

PRAX is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRAX($1.37B) has a higher market cap than CLRB($65.2M). PRAX YTD gains are higher at: 230.700 vs. CLRB (-42.960). CLRB has higher annual earnings (EBITDA): -51.29M vs. PRAX (-163.59M). PRAX has more cash in the bank: 357M vs. CLRB (34.3M). CLRB has less debt than PRAX: CLRB (513K) vs PRAX (1.66M). PRAX has higher revenues than CLRB: PRAX (1.61M) vs CLRB (0).
CLRBPRAXCLRB / PRAX
Capitalization65.2M1.37B5%
EBITDA-51.29M-163.59M31%
Gain YTD-42.960230.700-19%
P/E RatioN/AN/A-
Revenue01.61M-
Total Cash34.3M357M10%
Total Debt513K1.66M31%
FUNDAMENTALS RATINGS
CLRB: Fundamental Ratings
CLRB
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
81
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLRBPRAX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 11 days ago
86%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
CLRB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NGVT48.412.17
+4.69%
Ingevity Corp
NHTC5.600.12
+2.19%
Natural Health Trends Corp
OPY61.471.27
+2.11%
Oppenheimer Holdings
NE34.700.32
+0.93%
Noble Corp
SNY47.980.20
+0.42%
Sanofi ADS

PRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with VERU. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then VERU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
+1.28%
VERU - PRAX
35%
Loosely correlated
-0.30%
INZY - PRAX
34%
Loosely correlated
-0.71%
ZYME - PRAX
34%
Loosely correlated
-1.49%
CLRB - PRAX
33%
Loosely correlated
-3.11%
STRO - PRAX
33%
Poorly correlated
-1.11%
More